John Crowley has balanced his children’s need for a cure and his pursuit of profits for 14 years.

When the Princeton, N.J., businessman became head of his first biotech company in 2000, he was desperate to find a drug to keep his two youngest children alive. He succeeded, helping develop medicine that kept their hearts from failing.